Discovery of a Cushing's syndrome protein kinase A mutant that biases signaling through type I AKAPs
Mitchell H Omar,Dominic P Byrne,Safal Shrestha,Tyler M Lakey,Kyung-Soon Lee,Sophia M Lauer,Kerrie B Collins,Leonard A Daly,Claire E Eyers,Geoffrey S Baird,Shao-En Ong,Natarajan Kannan,Patrick A Eyers,John D Scott,Mitchell H. Omar,Dominic P. Byrne,Tyler M. Lakey,Sophia M. Lauer,Kerrie B. Collins,Leonard A. Daly,Claire E. Eyers,Geoffrey S. Baird,Patrick A. Eyers,John D. Scott
DOI: https://doi.org/10.1126/sciadv.adl1258
IF: 13.6
2024-02-22
Science Advances
Abstract:Adrenal Cushing's syndrome is a disease of cortisol hypersecretion often caused by mutations in protein kinase A catalytic subunit (PKAc). Using a personalized medicine screening platform, we discovered a Cushing's driver mutation, PKAc-W196G, in ~20% of patient samples analyzed. Proximity proteomics and photokinetic imaging reveal that PKAc W196G is unexpectedly distinct from other described Cushing's variants, exhibiting retained association with type I regulatory subunits (RI) and their corresponding A kinase anchoring proteins (AKAPs). Molecular dynamics simulations predict that substitution of tryptophan-196 with glycine creates a 653–cubic angstrom cleft between the catalytic core of PKAc W196G and type II regulatory subunits (RII), but only a 395–cubic angstrom cleft with RI. Endocrine measurements show that overexpression of RIα or redistribution of PKAc W196G via AKAP recruitment counteracts stress hormone overproduction. We conclude that a W196G mutation in the kinase catalytic core skews R subunit selectivity and biases AKAP association to drive Cushing's syndrome.
multidisciplinary sciences